Refractive Surgery News

Join White as he discusses the burden cataract post-operative regimens place on both patients and staff, and ways to “stop the madness.” He also gives a history of cataract post-op and the breakthroughs that led to today’s most common regimens.

Phacoemulsification and MIGS rank among the most important innovations in ophthalmology over the past 40 years, according to an email poll of more than 100 readers conducted by Healio/Ocular Surgery News.

Toric IOLs are an invaluable tool in the cataract surgeon’s armamentarium, not difficult to use and beneficial for the practice and patients, according to one presenter.

Twice-daily Vuity for presbyopia met its primary efficacy endpoint in the phase 3 VIRGO trial, according to a press release from Allergan/AbbVie.

To celebrate the 40th anniversary of Healio/Ocular Surgery News, we are looking back at major developments in ophthalmology. In this submission to the 40th anniversary collection on Healio/OSN, James J. Wynne, PhD, reflects on the discovery of laser refractive surgery.

In a second phase 3 registration trial, Nyxol helped reverse pharmacologically induced mydriasis at 90 minutes, according to a press release from Ocuphire Pharma.

The FDA approved the EVO/EVO+ Visian implantable Collamer lens for the correction of myopia and myopia with astigmatism, according to a press release from STAAR Surgical.

In this episode I share my top 5 predictions in ophthalmology for 2022, including my thoughts on the future of COVID-19 and ocular gene therapy.

For decades, eye care providers dedicated the majority of our attention to vision clarity.

ORLANDO — In this Healio Video Perspective from Cataract Surgery: Telling It Like It Is, George O. Waring IV, MD, FACS, discusses an update to the Catalys Precision laser system from Johnson & Johnson Vision.